Jim Yellson

PHD Doctor of Philosophy,  Cleveland Clinic 

Location: India

Consulting Services

Scientific Writing Biostatistics Data Science-Bioinformatics

Areas Of Interest

Spinal Cord Neoplasms, Intramedullary Reinforcing Factor Accumbens, Nucleus Blogging Techniques, Pronuclear Transfer Epithelial Mesenchymal Transition gag Gene Related Protein Choledojejunostomies Proteus-Like Syndrome alpha-Lactalbumin B Masses, Ideal Body Junction, Gastroesophageal Serum Amyloid A Protein Physician Patient Relationships Xenograft Transplantation Immunoglobulin Fv Fragment Lymphomas, Small-Cell Prolapses, Urogenital Battered Child Syndrome Amikalem Sites, Immunodominant Spinocerebellar Disease Aspirin-Dipyridamole Drug Combination Immunoelectron Microscopy Research, Laboratory Brooms, Spanish

Professional Narrative

Dr. Jim Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 2015
Director Medicine, Harvard Med 1989

Education

Director Medicine, Perelman School of Medicine 2005
Director Medicine, Yale School of Medicine 1990

Referees


Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :